Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 3/5 criteria met. Data as of 17/09/2026.
- ✅ Price trend passed
- ✅ Growth passed
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): the price has been multiplied by at least 1.5.
Price change 2018 → 2019: 38.34%
Price change 2019 → 2020: -25.16%
Price change 2020 → 2021: 52.62%
Price change 2021 → 2022: -3.11%
Price change 2022 → 2023: -2.47%
Price change 2023 → 2024: 21.45%
Price change 2024 → 2025: 9.18%
Price change 2025 → 2026: 1.85%
Price change 2026 (year to date): 2.17%
Financial growth
Revenue CAGR (8 years): 6.31%
Earnings CAGR (8 years): 8.89%
Growth status: positive trend (>1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 1.06
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 10.99
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 3.21% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Coface S.A. | 10.8 | 1.06 | +0.8 % | 🔒 |
| SCOR Se | 6.8 | 0.81 | +5.9 % | – |
| Edenred S.A. | 12.2 | – | +7.2 % | – |
| Amundi S.A. | 13.1 | 0.16 | +8.4 % | ★ 5/5 |
| Société Générale S.A. | 7.8 | 2.38 | +2.3 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|